What is pathophysiology of Lung cancer?

['聽聽這個頁面']

肺癌的病理生理學是什麼?

肺癌的病理生理學指的是肺癌發展和進展過程中正常生理過程和機制的變化.

肺癌是一種複雜的疾病,

癌細胞會形成腫瘤並擴散到身體其他部位,

肺癌的病理生理學涉及多種因素,

肺細胞的DNA可能發生基因突變,

癌症是因為吸入大量的,,石棉以及空氣污染而引起的.

肺癌可分為兩種主要類型:小細胞肺癌 (SCLC) 和非小細胞肺癌 (NSCLC).

這些肺癌的病理生理學可能有所不同,

肺癌的病理生理學也涉及癌細胞與周圍組織,

癌細胞可以逃避免疫系統,

提供癌細胞支持環境, 促進腫瘤生長及轉移.

肺癌的病理生理學是一個複雜而動態的過程,

['其他資料']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Li Z, Qian Y, Li W, Liu L, Yu L, Liu X, Wu G, Wang Y, Luo W, Fang F, Liu Y, Song F, Cai Z, Chen W, Huang W: Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening. iScience. 2020, 23 (8): 101411.

Nurwidya F, Syahruddin E, Yunus F: Pain management in lung cancer. Adv Respir Med. 2016, 84 (6): 331-336.

Khan KA, Kennedy MP, Moore E, Crush L, Prendeville S, Maher MM, Burke L, Henry MT: Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis. Lung. 2015, 193 (1): 71-7.

Paramanantham A, Asfiya R, Das S, McCully G, Srivastava A: Extracellular Vesicle (EVs) Associated Non-Coding RNAs in Lung Cancer and Therapeutics. Int J Mol Sci. 2022, 23 (21): .

Lee D, Kim Y, Chung C: Scientific Validation and Clinical Application of Lung Cancer Organoids. Cells. 2021, 10 (11): .

Mucchietto V, Crespi A, Fasoli F, Clementi F, Gotti C: Neuronal Acetylcholine Nicotinic Receptors as New Targets for Lung Cancer Treatment. Curr Pharm Des. 2016, 22 (14): 2160-9.

['免責聲明:醫療使用']

['提供醫療建議或專業服務.']

['提供給我們的資訊不應用於診斷或治療健康問題或疾病,']

['特別是數字內容不準確, 例如確診患有特定疾病的人數.']

['請隨時向您的醫生或其他合格的醫療人員諮詢您的病情. 請勿因為您在本網站上閱讀的內容而忽視專業醫療建議或延遲尋求. 如果您認為您可能有醫療緊急情況,請立即致電911或前往最近的急診室. 本網站或其使用並未建立醫師-病人關係. BioMedLib及其員工或本網站的任何貢獻者,都不會就此提供的信息或其使用作出任何明示或暗示的聲明.']

['免責聲明:版權所有']

['該法案為那些認為網路上出現的內容侵犯了他們在美國版權法下的權利的版權所有者提供了補救. ']

['您 (或您的代理人) 可向我們發送通知, 要求移除內容或資料,或封鎖存取.']

['請見"聯絡方式"一節.']

['要求您的侵權聲明包含以下資訊: (1) 侵權聲明所涉及的著作的描述; (2) 侵權聲明所涉及的內容的描述及足以讓我們找到內容的資訊; (3) 您的聯絡方式,']

['(5) 您在作假宣誓的懲罰下簽署的聲明, 表示通知中的資訊是正確的,']

['且 (6) 版權所有者或授權代表其行動的人士的實物或電子簽名.']

['請填寫您的投訴內容.']

['聯絡方式']

['請發送電子郵件給我們,']

What is pathophysiology of lung cancer?

The pathophysiology of lung cancer refers to the changes in the normal physiological processes and mechanisms that occur in the development and progression of lung cancer.

Lung cancer is a complex disease that arises from the uncontrolled growth and division of abnormal cells in the lungs.

These cells can form tumors and spread to other parts of the body, leading to various symptoms and complications.

The pathophysiology of lung cancer involves several factors, including genetic mutations, environmental factors, and lifestyle choices.

Genetic mutations can occur in the DNA of lung cells, leading to uncontrolled cell growth and division.

These mutations can be inherited or acquired, and they can be caused by exposure to carcinogens, such as tobacco smoke, radon, asbestos, and air pollution.

Lung cancer can be classified into two main types: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC is further divided into three subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.

The pathophysiology of these types of lung cancer can differ, as they have different genetic mutations and respond differently to treatment.

The pathophysiology of lung cancer also involves the interaction between cancer cells and the surrounding tissue, including the immune system.

Cancer cells can evade the immune system, allowing them to grow and spread unchecked.

Additionally, the tumor microenvironment can promote tumor growth and metastasis by providing a supportive environment for cancer cells.

The pathophysiology of lung cancer is a complex and dynamic process, and researchers are continuously working to better understand the underlying mechanisms to develop more effective treatments and improve patient outcomes.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.